Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up.
about
Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosisEpidemiology and disease burden of tuberculosis in children: a global perspectivePreventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutionsScaling up programmatic management of drug-resistant tuberculosis: a prioritized research agendaOutcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalenceCulture-confirmed childhood tuberculosis in Cape Town, South Africa: a review of 596 cases.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerDrug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.UNSUSPECTED FATAL DRUG-RESISTANT TUBERCULOSIS IN A CLOSELY MONITORED CHILD: A PLEA FOR IMPROVED SOURCE-CASE TRACING AND DRUG SUSCEPTIBILITY TESTINGAdverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study.Controversies in preventive therapy for children contacts of multidrug-resistant tuberculosis.Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcomeTowards tuberculosis elimination: an action framework for low-incidence countriesWhy do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?Decentralised care for the management of child contacts of multidrug-resistant tuberculosisManagement of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.Pharmacokinetics and Safety of Ofloxacin in Children with Drug-Resistant Tuberculosis.Drug-resistant tuberculosis: controversies and challenges in pediatrics.Contact investigation for tuberculosis: a systematic review and meta-analysis.Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.Preventing nosocomial MDR TB transmission in sub Saharan Africa: where are we at?Antimicrobial resistance in tuberculosis: an international perspective.Isoniazid-resistant tuberculosis in children: a systematic reviewAdvances in Drug Discovery and Development for Pediatric Tuberculosis.Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysisPediatric TB: issues related to current and future treatment options.Multi-drug resistant childhood tuberculosis.Caring for children with drug-resistant tuberculosis: practice-based recommendations.Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.Dilemma of managing asymptomatic children referred with 'culture-confirmed' drug-resistant tuberculosisAdverse effects of oral second-line antituberculosis drugs in children.Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays.Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.A six months follow-up on children less than 6 years old in contact with smear positive tuberculosis patients, varamin city, tehran, iran.Drug-resistant tuberculosis: pediatric guidelines.
P2860
Q24246070-74AEF765-3F70-4CC4-8EED-B0D8851161E0Q26849514-F00E0FA1-4C13-46B1-8170-1A9888D04A62Q26851747-7912FFF5-FDBF-4C26-9F1F-607A48824BAAQ28473126-04CF6562-68D5-4FE9-9FBE-9A3273EBE2D2Q28483868-629C1465-D243-429A-8A3C-D58B74D588D9Q33307793-BA2FB031-566F-4226-8559-6F423FC821FAQ33650105-BAD196D3-E69E-4755-8C1A-E70CC0894D3FQ33801345-77967FCF-C854-4E79-9E26-3C34742ECE23Q34058444-2477FE5A-1D16-458A-B61C-B7769B2EEAA9Q34551560-87316E04-4280-4150-9288-B7568EE1CC81Q34974337-79703AA2-C1CF-4EAB-A846-BA567C86A622Q35007404-7718E3DD-6CA6-4BF0-8E3E-6269AD872A97Q35274696-14FCF672-AC66-43CC-9E05-7C0655F90C7AQ35344151-08964AEE-777B-4E95-A668-6CE2B48DD1F5Q35718522-A13E9813-A9D9-40DD-8E67-698CAFBF09A9Q35718529-08A4A9A6-F886-4D81-AC19-6370180E0046Q35787450-06918406-01EA-4F0C-81C0-14249946C11CQ36075800-ADC9A689-54AB-4018-A7CA-846A6568F8D7Q36322140-24B2483B-811E-49A3-914A-BAC3B94567ADQ36498173-B2C37476-A4C7-4EED-8ACD-04F358AFE931Q36511908-06F39144-9D16-4A0E-8481-C9ED4F67EFBEQ36647864-5DEE016A-83C1-493C-A48B-0D17E330B498Q36670877-03CA400A-B507-4C51-AFAB-4765B47B9B9AQ37004599-D727DE6E-198D-47E2-A2EB-4A9354BF0518Q37134041-5458FED5-6DAE-4AC3-94A9-9B856B1456D0Q37473011-B157AECF-E0B8-438B-BB22-A68C33B1AE73Q37573756-3C4607E0-11DC-43C0-93D5-14411BCADE98Q37824823-76983B97-3D99-4790-A174-748CC0207C61Q38043978-99EA3165-EACE-45FF-AD42-7C7D89EA9787Q38660254-354402F2-1AED-4672-AC30-97324D6E45A2Q38797948-C4CEDBBB-47EA-4D19-BF05-72C166D500F0Q38837774-99EACD9C-BD0A-45E3-B417-D87794B8411CQ38886442-B0FF8090-B75D-4DC2-A9D5-5FDFA32A36BDQ40660539-6C441985-D022-416A-A87B-1FC62AA5817DQ41744320-B8B50E19-F6B4-45A0-A33C-085DDE346994Q42246655-D8A00DA9-5F7B-4642-8810-87C61CD8CD34Q42547110-79285DDF-B264-4ACA-B1F2-D2DEF9F81103Q42715629-6E65EE11-012F-4951-8DDD-4BF897CA4A85Q42733147-68DB8E65-913A-4B7E-94A3-A9FBE1F32AFCQ45014161-FCD3D62C-68CD-4049-9DAB-3BFCEFEE4DDE
P2860
Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Evaluation of young children i ...... culosis: a 30-month follow-up.
@en
Evaluation of young children i ...... culosis: a 30-month follow-up.
@nl
type
label
Evaluation of young children i ...... culosis: a 30-month follow-up.
@en
Evaluation of young children i ...... culosis: a 30-month follow-up.
@nl
prefLabel
Evaluation of young children i ...... culosis: a 30-month follow-up.
@en
Evaluation of young children i ...... culosis: a 30-month follow-up.
@nl
P2093
P356
P1433
P1476
Evaluation of young children i ...... culosis: a 30-month follow-up.
@en
P2093
H Simon Schaaf
Magdalene Kennedy
Peter B Hesseling
Peter R Donald
Robert P Gie
P304
P356
10.1542/PEDS.109.5.765
P407
P50
P577
2002-05-01T00:00:00Z